Fridman R, Fuerst T R, Bird R E, Hoyhtya M, Oelkuct M, Kraus S, Komarek D, Liotta L A, Berman M L, Stetler-Stevenson W G
Molecular Oncology Inc., Gaithersburg, Maryland 20878.
J Biol Chem. 1992 Aug 5;267(22):15398-405.
The 72-kDa gelatinase/type IV collagenase, a metalloproteinase thought to play a role in metastasis and in angiogenesis, forms a noncovalent stoichiometric complex with the tissue inhibitor of metalloproteinase-2 (TIMP-2), a potent inhibitor of enzyme activity. To define the regions of the 72-kDa gelatinase responsible for TIMP-2 binding, a series of NH2- and COOH-terminal deletions of the enzyme were constructed using the polymerase chain reaction technique. The full-length and the truncated enzymes were expressed in a recombinant vaccinia virus mammalian cell expression system (Vac/T7). Two truncated enzymes ending at residues 425 (delta 426-631) and 454 (delta 455-631) were purified. Like the full-length recombinant 72-kDa gelatinase, both COOH-terminally truncated enzymes were activated with organomercurial and digested gelatin and native collagen type IV. In contrast to the full-length enzyme, delta 426-631 and delta 455-631 enzymes were less sensitive to TIMP-2 inhibition requiring 10 mol of TIMP-2/mol of enzyme to achieve maximal inhibition of enzymatic activity. The activated but not the latent forms of the delta 426-631 and delta 455-631 proteins formed a complex with TIMP-2 only when excess molar concentrations of inhibitor were used. We also expressed the 205-amino acid COOH-terminal fragment, delta 1-426, and found that it binds TIMP-2. In addition, a truncated version of the 72-kDa gelatinase lacking the NH2-terminal 78 amino acids (delta 1-78) of the proenzyme retained the ability to bind TIMP-2. These studies demonstrate that 72-kDa gelatinases lacking the COOH-terminal domain retain full enzymatic activity but acquire a reduced sensitivity to TIMP-2 inhibition. These data suggest that both the active site and the COOH-terminal tail of the 72-kDa gelatinase independently and cooperatively participate in TIMP-2 binding.
72 kDa明胶酶/IV型胶原酶是一种金属蛋白酶,被认为在转移和血管生成中发挥作用,它与金属蛋白酶组织抑制剂-2(TIMP-2)形成非共价化学计量复合物,TIMP-2是一种有效的酶活性抑制剂。为了确定72 kDa明胶酶中负责与TIMP-2结合的区域,利用聚合酶链反应技术构建了该酶的一系列氨基末端和羧基末端缺失体。全长和截短的酶在重组痘苗病毒哺乳动物细胞表达系统(Vac/T7)中表达。纯化了两种截短的酶,其终止于第425位残基(δ426 - 631)和第454位残基(δ455 - 631)。与全长重组72 kDa明胶酶一样,两种羧基末端截短的酶都能用有机汞激活,并能消化明胶和天然IV型胶原。与全长酶不同的是,δ426 - 631和δ455 - 631酶对TIMP-2抑制的敏感性较低,需要10摩尔的TIMP-2/摩尔的酶才能实现对酶活性的最大抑制。只有当使用过量摩尔浓度的抑制剂时,δ426 - 631和δ455 - 631蛋白的激活形式而非潜伏形式才与TIMP-2形成复合物。我们还表达了205个氨基酸的羧基末端片段δ1 - 426,发现它能结合TIMP-2。此外,一种缺失酶原氨基末端78个氨基酸(δ1 - 78)的72 kDa明胶酶截短变体仍保留结合TIMP-2的能力。这些研究表明,缺乏羧基末端结构域 的72 kDa明胶酶保留了完整的酶活性,但对TIMP-2抑制的敏感性降低。这些数据表明,72 kDa明胶酶的活性位点和羧基末端尾巴独立且协同地参与TIMP-2结合。